BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gaggl M, Aigner C, Csuka D, Szilágyi Á, Prohászka Z, Kain R, Haninger N, Knechtelsdorfer M, Sunder-Plassmann R, Sunder-Plassmann G, Schmidt A. Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome. J Am Soc Nephrol 2018;29:1020-9. [PMID: 29282226 DOI: 10.1681/ASN.2016090995] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Kandari S, Chakurkar V, Gaikwad S, Agarwal M, Phadke N, Lobo V. High prevalence of CFHR deletions in Indian women with pregnancy-associated hemolytic uremic syndrome. Nephrology (Carlton) 2021. [PMID: 34796567 DOI: 10.1111/nep.14004] [Reference Citation Analysis]
2 McFarlane PA, Bitzan M, Broome C, Baran D, Garland J, Girard LP, Grewal K, Lapeyraque AL, Patriquin CJ, Pavenski K, Licht C. Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review. Can J Kidney Health Dis 2021;8:20543581211008707. [PMID: 33996107 DOI: 10.1177/20543581211008707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Haninger-Vacariu N, El-Hadi S, Pauler U, Foretnik M, Kain R, Prohászka Z, Schmidt A, Skuban N, Barth JA, Sunder-Plassmann G. Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report. Case Rep Obstet Gynecol 2019;2019:1030259. [PMID: 31934472 DOI: 10.1155/2019/1030259] [Reference Citation Analysis]
4 Szczepanski J, Spencer SK, Griffin A, Bowles T, Williams JM, Kyle PB, Dumas JP, Araji S, Wallace K. Acute kidney injury during pregnancy leads to increased sFlt-1 and sEng and decreased renal T regulatory cells in pregnant rats with HELLP syndrome. Biol Sex Differ 2020;11:54. [PMID: 32972452 DOI: 10.1186/s13293-020-00331-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Timmermans SAMEG, Werion A, Spaanderman MEA, Reutelingsperger CP, Damoiseaux JGMC, Morelle J, van Paassen P. The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives. Br J Haematol 2020;190:442-9. [PMID: 32342491 DOI: 10.1111/bjh.16626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Szczepanski J, Griffin A, Novotny S, Wallace K. Acute Kidney Injury in Pregnancies Complicated With Preeclampsia or HELLP Syndrome. Front Med (Lausanne) 2020;7:22. [PMID: 32118007 DOI: 10.3389/fmed.2020.00022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
7 Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G. An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy. Clin Kidney J 2019;12:333-7. [PMID: 31198225 DOI: 10.1093/ckj/sfz040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
8 Santoro D, La Russa A, Toteda G, Perri A, Vizza D, Lupinacci S, Lofaro D, Pellicanò V, Granese R, Versaci A, Siligato R, Piccoli GB, Bonofiglio R. Identification of a New Complement Factor H Mutation in a Patient With Pregnancy-Related Acute Kidney Injury. Kidney Int Rep 2020;5:1603-7. [PMID: 32954088 DOI: 10.1016/j.ekir.2020.06.028] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Aigner C, Gaggl M, Kain R, Prohászka Z, Garam N, Csuka D, Sunder-Plassmann R, Piggott LC, Haninger-Vacariu N, Schmidt A, Sunder-Plassmann G. Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic Microangiopathy. J Clin Med 2020;9:E964. [PMID: 32244370 DOI: 10.3390/jcm9040964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Scully M. How to evaluate and treat the spectrum of TMA syndromes in pregnancy. Hematology Am Soc Hematol Educ Program 2021;2021:545-51. [PMID: 34889427 DOI: 10.1182/hematology.2021000290] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bateman S, Ladhani M, Jesudason S. Successful Subsequent Pregnancy in a Woman Receiving Eculizumab for Pregnancy-Associated Atypical Haemolytic Uraemic Syndrome. Case Rep Nephrol 2019;2019:2738723. [PMID: 31687234 DOI: 10.1155/2019/2738723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Aigner C, Gaggl M, Stemer G, Eder M, Böhmig G, Kain R, Prohászka Z, Garam N, Csuka D, Sunder-Plassmann R, Piggott LC, Haninger-Vacariu N, Schmidt A, Sunder-Plassmann G. Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohort. J Nephrol 2021. [PMID: 33599971 DOI: 10.1007/s40620-021-00981-8] [Reference Citation Analysis]
13 Cadet B, Meshoyrer D, Kim Z. Atypical hemolytic uremic syndrome: when pregnancy leads to lifelong dialysis: a case report and literature review. Cardiovasc Endocrinol Metab 2021;10:225-30. [PMID: 34765894 DOI: 10.1097/XCE.0000000000000247] [Reference Citation Analysis]
14 Sarno L, Tufano A, Maruotti GM, Martinelli P, Balletta MM, Russo D. Eculizumab in pregnancy: a narrative overview. J Nephrol 2019;32:17-25. [PMID: 30159857 DOI: 10.1007/s40620-018-0517-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
15 Timmermans SAMEG, van Paassen P. The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation. J Clin Med 2021;10:3034. [PMID: 34300201 DOI: 10.3390/jcm10143034] [Reference Citation Analysis]
16 Li J, Guo L, Shi S, Zhou X, Zhu L, Liu L, Lv J, Zhang H. The Role of Complement in Microangiopathic Lesions of IgA Nephropathy. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.03.028] [Reference Citation Analysis]
17 Grand'Maison S, Lapinsky S. Insights into pregnancy associated and atypical hemolytic uremic syndrome. Obstet Med 2018;11:137-40. [PMID: 30214480 DOI: 10.1177/1753495X18780099] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Carney EF. Thrombotic microangiopathy: Pregnancy outcomes in aHUS. Nat Rev Nephrol 2018;14:143. [PMID: 29332932 DOI: 10.1038/nrneph.2018.3] [Reference Citation Analysis]
19 Fakhouri F, Frémeaux-Bacchi V. Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics. Nat Rev Nephrol 2021;17:543-53. [PMID: 33953366 DOI: 10.1038/s41581-021-00424-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Korotchaeva Y, Kozlovskaya N, Shifman E, Kamyshova E, Bobrova L, Demyanova K, Moiseev S. Complement-activating conditions as potential triggers of pregnancy-related atypical haemolytic uraemic syndrome. Clin Kidney J 2021;14:2620-2. [PMID: 34950475 DOI: 10.1093/ckj/sfab163] [Reference Citation Analysis]
21 Haninger-Vacariu N, Aigner C, Gaggl M, Kain R, Prohászka Z, Böhmig GA, Sunder-Plassmann R, Sunder-Plassmann G, Schmidt A. Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy. Clin Kidney J 2021;14:1255-60. [PMID: 33841869 DOI: 10.1093/ckj/sfaa113] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Stefanovic V. The Extended Use of Eculizumab in Pregnancy and Complement Activation⁻Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys-The Future Is Now? J Clin Med 2019;8:E407. [PMID: 30909646 DOI: 10.3390/jcm8030407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
23 Khan ST, Naqvi R, Rashid R, Naqvi SA. A rare presentation of Kikuchi Disease with Hemolytic Uremic Syndrome. Pak J Med Sci 2019;35:586-8. [PMID: 31086556 DOI: 10.12669/pjms.35.2.735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Haninger-Vacariu N, Aigner C, Kain R, Prohászka Z, Gaggl M, Böhmig GA, Piggott LC, Sunder-Plassmann R, Sunder-Plassmann G, Schmidt A. Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy. Kidney Med 2020;2:213-7. [PMID: 32734241 DOI: 10.1016/j.xkme.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 So S, Fischer E, Gangadharan Komala M, Bose B. Postpartum atypical hemolytic uremic syndrome: Evaluating thrombotic microangiopathy in the pregnant woman. Obstet Med 2021;14:105-8. [PMID: 34394720 DOI: 10.1177/1753495X20926043] [Reference Citation Analysis]